These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 17932867

  • 1. Vogt-Koyanagi-Harada disease after head trauma.
    Accorinti M, Pirraglia MP, Corsi C, Caggiano C.
    Eur J Ophthalmol; 2007; 17(5):847-52. PubMed ID: 17932867
    [Abstract] [Full Text] [Related]

  • 2. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M, Gilardi M, Nardella C, Amorelli GM, Pesci FR.
    Eur J Ophthalmol; 2015 Oct 21; 25(6):e127-30. PubMed ID: 25982211
    [Abstract] [Full Text] [Related]

  • 3. [Vogt-Koyanagi-Harada disease].
    Kjeka O, Krohn J.
    Tidsskr Nor Laegeforen; 2005 Aug 25; 125(16):2195-7. PubMed ID: 16138134
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
    Karacorlu M, Arf Karacorlu S, Ozdemir H.
    Eur J Ophthalmol; 2006 Aug 25; 16(3):481-3. PubMed ID: 16761256
    [Abstract] [Full Text] [Related]

  • 5. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA, Sanchis ME, Fernandez-Munoz M.
    J Neuroophthalmol; 2007 Mar 25; 27(1):36-40. PubMed ID: 17414871
    [Abstract] [Full Text] [Related]

  • 6. Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.
    Cuevas M, de-la-Torre A, Córdoba A.
    Ocul Immunol Inflamm; 2018 Mar 25; 26(7):1101-1106. PubMed ID: 28548582
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
    Sakata VM, da Silva FT, Hirata CE, de Carvalho JF, Yamamoto JH.
    Autoimmun Rev; 2014 Mar 25; 13(4-5):550-5. PubMed ID: 24440284
    [Abstract] [Full Text] [Related]

  • 8. Vogt-Koyanagi-Harada disease.
    O'Keefe GA, Rao NA.
    Surv Ophthalmol; 2017 Mar 25; 62(1):1-25. PubMed ID: 27241814
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E, Ohguro N, Yamamoto S, Nakagawa Y, Imoto Y, Tano Y.
    Am J Ophthalmol; 2002 Sep 25; 134(3):454-6. PubMed ID: 12208266
    [Abstract] [Full Text] [Related]

  • 10. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M.
    Indian J Ophthalmol; 2016 Jan 25; 64(1):98. PubMed ID: 26953036
    [No Abstract] [Full Text] [Related]

  • 11. Vogt-Koyanagi-Harada syndrome with intracranial meningioma: an as yet unreported association.
    Kumar A, Chhabra MS, Prakash G, Kulkarni AD.
    Can J Ophthalmol; 2005 Dec 25; 40(6):725-8. PubMed ID: 16518897
    [Abstract] [Full Text] [Related]

  • 12. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    Zhang Q, Fan X, Tian M, Han H.
    BMC Nephrol; 2020 Jul 13; 21(1):272. PubMed ID: 32660433
    [Abstract] [Full Text] [Related]

  • 13. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
    Ikeda N, Hayasaka S, Kadoi C, Nagaki Y.
    Ophthalmologica; 1999 Jul 13; 213(3):197-9. PubMed ID: 10202295
    [Abstract] [Full Text] [Related]

  • 14. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD, Rathinam SR, Cunningham ET.
    Retina; 2010 Jul 13; 30(7):1113-21. PubMed ID: 20168275
    [Abstract] [Full Text] [Related]

  • 15. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
    Hashizume K, Imamura Y, Fujiwara T, Machida S, Ishida M, Kurosaka D.
    Retina; 2016 Feb 13; 36(2):415-21. PubMed ID: 26352553
    [Abstract] [Full Text] [Related]

  • 16. Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
    Koong LR, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL.
    Ocul Immunol Inflamm; 2021 Aug 18; 29(6):1212-1215. PubMed ID: 34505819
    [Abstract] [Full Text] [Related]

  • 17. [Vogt-Koyanagi-Harada syndrome in children].
    Laghmari M, Karim A, Ibrahimy W, Essakalli NH, Mohcine Z.
    J Fr Ophtalmol; 2002 Jun 18; 25(6):636-40. PubMed ID: 12223954
    [Abstract] [Full Text] [Related]

  • 18. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
    Matsuo T, Masuda I, Ota K, Yamadori I, Sunami R, Nose S.
    Acta Med Okayama; 2007 Oct 18; 61(5):305-9. PubMed ID: 17971847
    [Abstract] [Full Text] [Related]

  • 19. [Vogt-Koyanagi-Harada disease].
    Bonnet C, Daudin JB, Monnet D, Brézin A.
    J Fr Ophtalmol; 2017 Jun 18; 40(6):512-519. PubMed ID: 28579215
    [Abstract] [Full Text] [Related]

  • 20. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
    Inomata H, Rao NA.
    Am J Ophthalmol; 2001 May 18; 131(5):607-14. PubMed ID: 11336935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.